BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

Bio Techne Corporation Announces CE IVD Marking For Ella Benchtop Immunoassay Platform In European Union

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU Enables diagnostic assay developers to leverage a simplified platform tha...

February 18, 2026 | News

CStone Pharmaceuticals Secures US FDA IND Clearance For Phase II Trial Of CS2009 In Advanced Solid Tumours

CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA...

February 17, 2026 | News

Omics Empower Expands Spatial Transcriptomics Services With Xenium Platform In Hong Kong

Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In S...

February 16, 2026 | News

HanchorBio Secures FDA Orphan Drug Designation For HCB101 In Gastric Cancer

First SIRPα-IgG4 Fc Fusion Protein Granted Orphan Status in Gastric Cancer HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnolog...

February 16, 2026 | News

Alphamab Oncology Advances JSKN003 Into Phase III Trial For HER2 Positive Advanced Colorectal Cancer

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005...

February 16, 2026 | News

Ribo And Ribocure Sign Global Licensing Deal With Madrigal For Six siRNA Programmes In MASH

Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") announced that they have entere...

February 13, 2026 | News

ArkBio Receives FDA IND Clearance For AK3280 Phase Two Trial In Idiopathic Pulmonary Fibrosis

Shanghai Ark Biopharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) applicat...

February 13, 2026 | News

WuXi Vaccines Secures ANVISA GMP Certification For Suzhou Fill And Finish Facility

WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced that...

February 13, 2026 | News

Insilico Medicine And China Medical System Forge Multi Project AI Drug Discovery Alliance

Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Ho...

February 12, 2026 | News

Helix Partners With Mawi DNA To Broaden Access To Non Invasive Genomic Sample Collection

Helix, the leading enterprise genomics company, has partnered with Mawi DNA Technologies, a leader in DNA sample collection and storage, to expa...

February 12, 2026 | News

SOPHiA GENETICS Expands US Footprint With Two Major Health System Partnerships

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, announced the addition of two of the largest U.S. healthcare systems ...

February 12, 2026 | News

Aucta Pharmaceuticals Launches PYQUVI Oral Suspension For Duchenne Muscular Dystrophy In The US

Aucta Pharmaceuticals is pleased to announce the late January launch of PYQUVI oral suspension 22.75 mg/mL. PYQUVI, a corticosteroid indicated f...

February 10, 2026 | News

Kelun Biotech Wins China Approval For Sacituzumab Tirumotecan In Advanced Breast Cancer

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application for its TROP2-dir...

February 09, 2026 | News

Delonix Bioworks Secures China IND Clearance For MenB Vaccine Candidate DX 104

Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B...

February 09, 2026 | News

Stay Connected